Differential Diagnosis of Respiratory Virus & COVID 19
Antigen Combo Tests (SARS-CoV-2, Flu A, Flu B, RSV)
Reliable antigen combo detection kits of European research, development, and construction.
SARS-CoV-2 + Flu A + Flu B + RSV quad kit is a coloured chromatographic immunoassay (One Step) for the simultaneous qualitative detection of nucleoprotein antigen of SARS-CoV-2, Influenza type A, Influenza type B and Respiratory Syncytial Virus from nasopharyngeal swab samples from patients suspected of COVID-19 infection and/or Influenza A and/or Influenza B and/or Respiratory Syncytial Virus (RSV) infection. It offers a simple and highly sensitive screening assay as aid in the diagnosis of SARS-CoV-2 and/or Influenza type A and/or Influenza type B and/or RSV infection. Important in the diagnosis of respiratory infection by the new Coronavirus (SARS-CoV-2) due to the speed, reliability, and coincidence of results with Molecular Techniques without the requirement of specialized equipment.
Clinically, patients infected with SARS-CoV-2 exhibit symptoms such as olfactory and gustatory dysfunction, fever, dry cough, anosmia, fatigue, dyspnea, headache, diarrhea, and sore throat, followed by arterial and systemic complications.
COVID-19 usually causes pneumonia, which can develop into acute respiratory syndrome, leading to respiratory or multiorgan failure.
The following graph shows the progression of COVID 19:
This combo kit allows the differential diagnosis with other respiratory viruses, i.e. influenza and syncytial respiratory virus (mainly useful in children).
This differential diagnosis is particularly useful to rule out similar typical symptoms of other viruses to those of the coronavirus.
Large population groups can be tested quickly and reliably, without inconvenience to either them or the Health Staff.
- Easy diagnosis. Nasopharyngeal swab samples.
- No added equipment needed. Everything you need is included in the kit.
- Immediate results in 10 minutes!
- Very easy to use and interpretation of the results.
- Sensitivity: 96,0% *
- Specialty: 98,4% *